EU backs stroke prevention drug despite 256 deaths

LONDON (Reuters) – Doctors should exercise caution in using Boehringer Ingelheim’s new stroke prevention pill Pradaxa, following 256 cases of fatal bleeding, but the benefits of the medicine still outweigh its risks, European regulators said on Friday.